CIBC Private Wealth Group LLC Sells 7,500 Shares of Aemetis, Inc. (NASDAQ:AMTX)

CIBC Private Wealth Group LLC reduced its position in Aemetis, Inc. (NASDAQ:AMTX) by 2.9% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 250,190 shares of the specialty chemicals company’s stock after selling 7,500 shares during the quarter. CIBC Private Wealth Group LLC owned approximately 0.49% of Aemetis worth $704,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors have also recently modified their holdings of AMTX. FMR LLC boosted its holdings in Aemetis by 68.2% in the 3rd quarter. FMR LLC now owns 22,531 shares of the specialty chemicals company’s stock worth $52,000 after buying an additional 9,137 shares during the period. Clear Harbor Asset Management LLC purchased a new position in shares of Aemetis in the fourth quarter valued at about $44,000. Intech Investment Management LLC bought a new position in shares of Aemetis in the fourth quarter worth about $46,000. Bank of New York Mellon Corp grew its position in shares of Aemetis by 29.6% during the fourth quarter. Bank of New York Mellon Corp now owns 91,880 shares of the specialty chemicals company’s stock worth $247,000 after purchasing an additional 20,961 shares in the last quarter. Finally, SG Americas Securities LLC bought a new stake in Aemetis during the 4th quarter valued at approximately $87,000. 27.02% of the stock is owned by hedge funds and other institutional investors.

Aemetis Stock Performance

AMTX stock opened at $1.58 on Friday. The firm has a market cap of $83.98 million, a PE ratio of -0.70 and a beta of 1.30. The firm has a fifty day moving average price of $1.93 and a 200 day moving average price of $2.62. Aemetis, Inc. has a fifty-two week low of $1.45 and a fifty-two week high of $5.41.

Analyst Upgrades and Downgrades

Several research analysts have weighed in on the company. StockNews.com upgraded Aemetis to a “sell” rating in a research note on Wednesday, February 5th. Ascendiant Capital Markets upped their target price on shares of Aemetis from $18.00 to $19.00 and gave the stock a “buy” rating in a research report on Monday, March 17th. Finally, HC Wainwright reiterated a “buy” rating and issued a $28.00 price target on shares of Aemetis in a research note on Friday, March 14th. One investment analyst has rated the stock with a sell rating, one has given a hold rating and three have issued a buy rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of “Hold” and an average price target of $14.56.

Aemetis Company Profile

Aemetis, Inc operates as a renewable natural gas and renewable fuels company. It operates through three segments: California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel. The company focuses on the operation, acquisition, development, and commercialization of technologies to produce low and negative carbon intensity renewable fuels that replace fossil-based products.